Build it and They Will Come: Primal Offers a Free GPCR Database to Attract Development Partners | GenomeWeb

G-Protein coupled receptors are a hot property for drug developers — according to some estimates, 70 percent of all drugs marketed worldwide are targeted against the protein superfamily — and several firms are finding some success marketing commercial GPCR databases. So why is drug discovery startup Primal giving away its newly compiled GPCR data via its website? “From a business standpoint, we felt that the best way to advertise is through our discoveries,” said George Gaitanaris, president and CEO.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.